Receive news by e-mail

#
 

Enter your e-mail in the field below to receive directly the news that appears on this page.

 

topics : related - all Explore

Shopping Categories

  1. 1. Cell Phones
  2. 2. Smartphones
  3. 3. Digital Cameras
  4. 4. Laptop Computers
  5. 5. Processors
  6. 6. Motherboards
  7. 7. LCD Monitors
  8. 8. Graphics Cards
  9. 9. GPS
  10. 10. Digital Camcorders
  11. 11. Printers
  12. 12. Desktop Computers
  13. 13. Sedans
  14. 14. Coupes & Convertibles
  15. 15. 4x4

Wikio Shopping

  1. 1. Automotive
  2. 2. Beauty & Fragrances
  3. 3. Books
  4. 4. Car/Motorbike
  5. 5. CD
  6. 6. Clothing, Accessories & Shoes
  7. 7. Communication
  8. 8. Computers
  9. 9. DVD
  10. 10. Electronics
  11. 11. Flowers & Gifts
  12. 12. Gourmet & Foods
  13. 13. Health & Personal Care
  14. 14. Home & Garden
  15. 15. Hotels
  16. 16. Household Appliances
  17. 17. Jewelry & Watches
  18. 18. Musical Instruments
  19. 19. Sports & Outdoors
  20. 20. Toys & Baby
  21. 21. Video Games

Participate



Schering-Plough



Sort by : relevance - date - popularity
3Vote!

Recall Roundup: November 20, 2009

Here is today's list of food safety recalls, product withdrawals and allergy alerts. The live links will take you directly to the official recall notices and company news releases that contain detailed information for each recall and alert. United States Allergy Alert: HP Hood, the manufacturer of Hannaford Eggnog , directs Hannaford Supermarkets to remove certain containers of the half-gallon size...

3Vote!

New Healthcare Paradigm: Technology, Value and Emergence

Above: Healthcare conference team. As the vitriolic debate on healthcare reform dominates the news, healthcare industry leaders continue to focus on several issues: innovation to drive growth and promote cost efficiencies; new offerings to generate higher value for each healthcare dollar invested; and the emergence of attractive new global markets and technologies. They recognize that continued economic...

3Vote!

Ligand Earns $2 Million Merck Milestone

Ligand Pharmaceuticals, Inc. has received $2 million in milestone payments from N. V. Organon, a subsidiary of Merck , through its research collaboration, which is due to expire at the end of December. “We have had a long and productive drug discovery relationship with Organon and Schering-Plough (which acquired Organon in November 2007) over the years for a range of research programs,”...

3Vote!

Dan Loeb's Third Point Starts New Stakes In Popular (BPOP), TransDigm (TDG), & Health Net (HNT)

This is the third quarter 2009 edition of our hedge fund portfolio tracking series. If you're unfamiliar with tracking hedge fund movements or SEC filings, check out our series preface on hedge fund 13F filings . Next up in our series is Dan Loeb's Third Point LLC. Third Point is a multi-billion dollar hedge fund that has seen annual returns greater than 15% since inception. Manager Dan Loeb focuses...

5Vote!

Ligand receives $2 million from Merck partnership

Ligand Pharmaceuticals Inc. said Thursday it received a $2 million milestone payment from Merck & Co. as part of a research collaboration. The company said the partnership covers a range of research programs. It is due to expire at the end of December. Ligand... Merck & Co - Business - Pharmaceutical - Biotechnology and Pharmaceuticals - Schering-Plough

4Vote!

Trubion CEO out in management shuffle

Peter Thompson , Trubion Pharmaceuticals' president, CEO, chairman of the board and co-founder, has retired. Steven Gillis , former lead director of Trubion's board, has been appointed executive chairman of the board and acting president. Michelle Burris , Trubion's senior vice president and chief financial officer, will assume the role of chief operating officer, and John Bencich , the company's...

4Vote!

Following Fred: How Hassan Will Spend His Time

Now that Fred Hassan is no longer the chief executive of Schering-Plough - or any other drugmaker - since Merck finally scooped up its rival, Fred has been busy accepting invitations to join the boards of various other corporations. Apparently, his experience selling drugmakers - don’t forget his time running Pharmacia - is seen as [...]

3Vote!

Schering-Plough’s Search for Biomarkers

Bio-IT World | SINGAPORE—“ If you Googled ‘biomarkers’ ten years ago, I think you’d end up with all kinds of websites on extraterrestrial life. Biomarkers: life in space!” jokes Erik Sprengers, site head of the Schering-Plough Translational Medicine Research Centre (TMRC).

3Vote!

Will the M&A Wave Push Financial ETFs Higher?

ETF Database submits: Over the past few weeks, there has been a resurgence in acquisition activity, fueling an already strong market rally. This news has spanned all regions of the economy ranging from the transportation sector (Burlington Northern ( BNI ) being taken over by Berkshire Hathaway ( BRK.A )) to pharmaceuticals (Schering Plough ( SGP ) being acquired by Merck ( MRK )). Most recently,...

3Vote!

Merck & Co remains confident in Zetia and Vytorin, despite studying questioning the drugs

USA-based Merck & Co, now the world’s number two drugmaker following its acquisition of Schering-Plough, says it remains confident about the safety and efficacy of its leading cholesterol-lowering drugs, despite the results of a much-anticipated head-to-head study which calls into question the level of effectiveness of Zetia (ezetimibe) and Vytorin. (ezetimibe and simvastatin).

3Vote!

Will Financial ETFs Ride the M&A Wave Higher?

Michael Johnston submits: Over the past few weeks, there has been a resurgence in acquisition activity, fueling an already strong market rally. This news has spanned all regions of the economy ranging from the transportation sector (Burlington Northern being taken over by Berkshire Hathaway) to pharmaceuticals (Schering Plough being acquired by Merck). Most recently, in the consumer sector, Kraft...

7Vote!

Another study questions Merck's cholesterol medicine, Zetia

EPAMerck, strenghthened by its acquisition of Schering-Plough, becomes the No. 2 drug makerORLANDO, Fla. -- A study released Sunday raises fresh concerns about Zetia and its cousin, Vytorin — drugs still taken by millions of Americans to lower cholesterol, despite...

4Vote!

Cramer’s Lightning Round: Buy Devon Energy Corp

Bullish Devon Energy Corp. (DVN), Apache Corp. (APA), ConAgra Foods Inc. (CAG), BP plc (NYSE:BP), Walgreens Company (NYSE:WAG) and Express Scripts Inc. (ESRX). Bearish Churchill Downs Inc. (CHDN), Chesapeake Energy Corporation (CHK), Tyson Foods Inc. (TSN) and CVS Caremark Corp. (CVS). Get the scoop on tomorrow’s hottest trade ideas – TODAY! [...]

4Vote!

Merck Strengthens Its Commitment to Advancing Cardiovascular Health Care

WHITEHOUSE STATION, N.J. - Following the completion of its merger with Schering-Plough, Merck today confirms and underscores its commitment to marketing and developing cardiovascular medicines for a range of cardiovascular disorders. Today's Merck has a robust portfolio and

4Vote!

Merck Strengthens Its Commitment to Advancing Cardiovascular Health Care

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Following the completion of its merger with Schering-Plough, Merck today confirms and underscores its commitment to marketing and developing cardiovascular medicines for a range of cardiovascular disorders. "Today's Merck has a robust portfolio and pipeline of cardiovascular medicines for conditions ranging from heart disease to metabolic syndrome. More...

The 3 latest articles published by users on Schering-Plough :

5Vote!

Oncology Roadmap: Brand Spending Benchmarks and Market Forecast to 2013

Oncology Roadmap: Brand Spending Benchmarks and Market Forecast to 2013 - aarkstore

omprehensive Forecasts AND Detailed Budget Benchmarks "Oncology Roadmap," explores the fiercely competitive oncology market in a way that no other available forecast can match. Our experienced analysts have reviewed thousands of historical and forecasted data points to provide the most comprehensive oncology market outlook ever. At the same time, brand budget benchmarks reveal spending in key areas...

2Vote!

New Report "Global Animal Health Market: Emerging Markets Driving Growth" available through Aarkstore Enterprise

New Report  Global Animal Health Market: Emerging Markets Driving Growth  available through Aarkstore Enterprise - aarkstore

The animal health market is growing, albeit at a slower rate, in the recessionary economic phase. Two factors are working in favor of the industry – pet owners’ love for their companion animals and the economic reasons for the treatment of livestock or farm animals. The “livestock” segment, a high-volume market that represents around 57% of the international animal health market is guided mostly by...

2Vote!

TransDigm Group (NYSE:TDG) Purchases Acme Aerospace from Actuant Corp.

TransDigm Group has purchased Acme Aerospace Business from Actuant Corporation for $40 million. TransDigm supplies aircraft companies with components and the addition of Acme Aerospace will accentuate TransDigm Group’s products. WPPS, a leading financial newsletter, is pleased to alert investors of stocks on the move. Sign...